Cologuard® HCP

This product is intended for US healthcare professionals only. See Indications & Important Information: https://exas.co/22va2h Important Information about the Cologuard products The Cologuard® and Cologuard Plus™ tests are intended for the qualitative detection of colorectal neoplasia associated DNA markers and for the presence of occult hemoglobin in human stool. A positive result may indicate the presence of colorectal cancer (CRC) or advanced precancerous lesions (APL) and should be followed by a colonoscopy. The Cologuard test and Cologuard Plus test are indicated to screen adults of either sex, 45 years or older, who are at average risk for CRC. These tests are not a replacement for diagnostic colonoscopy or surveillance colonoscopy in high-risk individuals. Cologuard products may produce false positive and false negative results. Performance when used for repeat testing has not been established. Refer to the Cologuard test Clinician Brochure (cologuardhcp.com/cologuard-brochure) or the Cologuard Plus test Clinician Brochure (cologuardhcp.com/cologuard-plus-brochure) for additional information about the benefits and risks of using each version of the Cologuard product for CRC screening. Rx Only. Cologuard and Cologuard Plus are trademarks of Exact Sciences Corporation. All other trademarks are the properties of their respective owners. © 2025 Exact Sciences Corporation. All rights reserved. M-US-CG-05046 April 2025

Website

https://www.cologuardhcp.com

External link for Cologuard® HCP

Industry

Biotechnology Research

Company size

5,001-10,000 employees

Headquarters

Madison, Wisconsin